PT Indo Medizen Sehat announced a private placement of 1,250 common shares at the price of KRW 90,300 per share for gross proceeds of KRW 112,875,000 on August 25, 2022. The transaction will include participation from returning investor MEDIZEN HUMANCARE Inc. The transaction has been approved by board of directors of MEDIZEN HUMANCARE Inc.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5,600 KRW | +0.18% | +10.89% | +40.00% |
1st Jan change | Capi. | |
---|---|---|
+40.00% | 9.35M | |
-42.02% | 7.92B | |
+11.13% | 3.51B | |
-0.92% | 2.18B | |
-21.69% | 1.97B | |
-24.10% | 1.58B | |
+24.33% | 792M | |
-10.48% | 690M | |
-28.78% | 532M | |
-1.29% | 303M |
- Stock Market
- Equities
- A236340 Stock
- News MEDIZEN HUMANCARE Inc.
- PT Indo Medizen Sehat announced that it expects to receive KRW 112.875 million in funding from MEDIZEN HUMANCARE Inc.